Researchers design ‘prodrug’ that targets cancer cells’ big appetite for glutamine, leaving healthy cells unharmed

Science Instruments in laboratory room. Science Research Concept.

Johns Hopkins Medicine researchers have revamped an anti-cancer drug to better target cancer cells and leave healthy tissues unharmed. Scientists have dubbed this type of targeted approach a “prodrug”—a medicine designed to release its payload in a particular area of the body and in no other areas.

High-resolution microscopy for analysis of protein complexes

Previous article

US overdose deaths may be peaking, but experts are wary

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations